A common treatment for Chronic Myeloid Leukemia (CML) includes the use of tyrosine kinase inhibitors (TKIs). Despite being an effective treatment for cancer, TKIs often cause off-target side effects. The goal of this project is to identify and highlight some of the side effects caused by TKIs to help physicians understand how to care for their patients during treatment. Through multiple methods , we have discovered a correlation between TKI treatment and a few hematological conditions. These conditions are also tangent to certain metabolic issues. After collecting the data and running statistical tests, we are beginning to prepare to write our findings for publication.
We are currently working on collecting, organizing, and documenting out methods, data, and results to begin writing our findings. Over the coming semester (Fall 2021), we hope to write and publish a paper on our current research.
Rachel Fisher and Olivia Kronick